Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Morphic Therapeutic, Inc. (a Wholly Owned Subsidiary Of Eli Lilly And Company)

Clinical trials sponsored by Morphic Therapeutic, Inc. (a Wholly Owned Subsidiary Of Eli Lilly And Company), explained in plain language.

Trials to join now! 1 Not yet finished but already full! 1 Completed 2

New pill aims to tame Crohn's Flare-Ups

Disease control Recruiting now

This study tests an experimental pill called MORF-057 (zotemtegrast) in 385 adults with moderate-to-severe Crohn's disease. The drug works by blocking a protein that drives gut inflammation. Participants will receive one of three doses of the drug or a placebo for 14 weeks to see…

Phase: PHASE2 • Sponsor: Morphic Therapeutic, Inc. (A Wholly Owned Subsidiary of Eli Lilly and Company) • Aim: Disease control

Last updated Jul 22, 2026 00:00 UTC